Stock Analysis
Incitec Pivot Full Year 2024 Earnings: EPS Misses Expectations
Incitec Pivot (ASX:IPL) Full Year 2024 Results
Key Financial Results
- Revenue: AU$5.41b (flat on FY 2023).
- Net loss: AU$477.7m (down by 273% from AU$276.3m profit in FY 2023).
- AU$0.25 loss per share (down from AU$0.14 profit in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Incitec Pivot EPS Misses Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates.
Looking ahead, revenue is forecast to stay flat during the next 3 years compared to a 11% growth forecast for the Chemicals industry in Australia.
Performance of the Australian Chemicals industry.
The company's shares are up 3.7% from a week ago.
Risk Analysis
You should always think about risks. Case in point, we've spotted 1 warning sign for Incitec Pivot you should be aware of.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About ASX:IPL
Incitec Pivot
Manufactures and distributes industrial explosives, industrial chemicals, and fertilizers in Australia and the United State.